<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Viome on Medium]]></title>
        <description><![CDATA[Stories by Viome on Medium]]></description>
        <link>https://medium.com/@MyViome?source=rss-bcea8272ef68------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/0*ACs1YVF0z8RK7fGn.jpg</url>
            <title>Stories by Viome on Medium</title>
            <link>https://medium.com/@MyViome?source=rss-bcea8272ef68------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Wed, 18 Nov 2026 17:11:21 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@MyViome/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Did The Viome Update Change Your Report? Welcome to The Gut Microbiome Revolution!]]></title>
            <link>https://medium.com/@MyViome/did-the-viome-update-change-your-report-welcome-to-the-gut-microbiome-revolution-93227dc07f62?source=rss-bcea8272ef68------2</link>
            <guid isPermaLink="false">https://medium.com/p/93227dc07f62</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[wellness]]></category>
            <category><![CDATA[microbiome]]></category>
            <dc:creator><![CDATA[Viome]]></dc:creator>
            <pubDate>Sat, 05 May 2018 00:10:04 GMT</pubDate>
            <atom:updated>2018-05-05T00:10:04.407Z</atom:updated>
            <content:encoded><![CDATA[<p>We are beyond excited that you are part of this revolutionary journey with us. When the newest Viome update rolled out, you witnessed firsthand the future of cutting edge gut microbiome research and the power of Artificial Intelligence (AI).</p><p>We understand it can be confusing to see your results being reclassified and reorganized, so we wanted to take a moment and explain what happened.</p><p><strong>First things first, your updated results are correct and 100% yours.</strong> The recent Viome update <em>improved </em>your report — you now have the most recent updated results, but you’ll notice much of your recommendations stayed the same (though some have changed <em>— we also have another update coming with changes in recommendations for some</em>).</p><p><strong>The update simply identified newly discovered microbes and reclassified other ones based on new scientific findings.</strong></p><p>We are a team of scientists working around the clock to better explain this emerging process for you. At every step of the way we are untangling technological challenges in presenting these discoveries to you, so we ask that you bear with us as we refine our delivery.</p><p>We are working tirelessly to provide the most up-to-date information on your gut microbiome.</p><p>You are part of the most important health advancement of our time. With cutting edge advancement comes constant change and improvement, here’s why…</p><h3>The Only Thing Constant in Life, Is Change</h3><p>Our metatranscriptomic technology is one-of-a-kind. Meaning, no one else out there has the insight we have. We’re compiling government databases, decades of scientific research, and ever-growing consumer results, which is a process of constant refinement.</p><p>With the power of our ongoing analyses comes the constant discovery of new microbes and uncovered functions , which results in the need for constant reclassification and incorporation of new insights into refining your recommendations. There are over 40 trillion microbes in your gut, so this is going to be an ongoing process.</p><p>We are digging deeper than ever before into a new area of science — <em>and you are a part of that.</em></p><p>We take billions of data points and distill them into tangible advice you can use to better your life. Just as Artificial Intelligence works to improve other areas of your life, you don’t have to completely understand the inner workings to reap the benefits of the technology.</p><p>We are working tirelessly to constantly improve our recommendations and user experience. As you can imagine, there are a lot of moving parts. So, we encourage you to view this as an exciting journey!</p><p>You might still be wondering why your report looks different — let’s take a closer look at that.</p><h3>What’s in a Name? Function Matters Most</h3><p><strong>Yes, your results are still your results. </strong>The change you saw was actually a reclassification of your microbes. Our mega-database continues to grow, and as it does our refinement of microbe categorization continues to improve. Most available databases use 16S technology to identify bacteria. With our metatranscriptomic technology, we can see much more detail and so we will need to continually update the organisms in our database.</p><p>Just as the scientific names of animals and plants change as new discoveries come to light, so do the names of microbes. Often what was thought to be a single species, when looked at in more detail is actually multiple strains. We will continue to use the most up to date classification of microbes as we learn more about them.</p><p>Here’s a quote on this from the peer-reviewed academic journal,<em> Clinical Microbiology Review</em>:</p><p>“<em>Problems remain in that the sequences in some databases are not accurate, there is no consensus in the quantitative definitions of genus or species based on 16S rRNA gene sequence data. The proliferation of species names based on minimal genetic and phenotypic differences raises communication difficulties, and the microheterogeneity in 16S rRNA gene sequence within a species is common</em>.”<a href="https://www.ncbi.nlm.nih.gov/pubmed/15489351">1</a></p><p>Meaning, there are such subtle differences in these microbes that the previously used 16S rRNA gene sequencing couldn’t see what we can see. So, it’s to be expected that there will be fine tuning of existing data sets.<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520958/">2</a></p><p><strong>What is most important isn’t the name — it is the function of these microbes.</strong> It’s critical to understand that the value in your recommendations comes from the <em>functions </em>of your microbes. In other words, the microbial metabolic and signaling pathways that we see happening in your gut. We are making recommendations based on their activity.</p><p>We understand that names can make conversations easier, but remember — our recommendations are based on the function. <strong>So, when you got your update — just the <em>names</em> of your microbes have changed, not what the microbes are doing.</strong></p><p>This idea is similar to how we’ve called the same illness by different names over the years. Chronic fatigue syndrome, chronic inflammatory response syndrome, fibromyalgia, and rheumatoid arthritis sometimes look the same, but the most important consideration is the root cause of these diseases. In the same way, we care MUCH more whether a particular microbe is producing harmful lipopolysaccharides over what we name it — because classification is under constant refinement.</p><p><strong>The metabolic pathways and functions of these microbes are what matter most to your health and wellness — which is exactly what the Viome AI system keeps it’s focus on.</strong></p><p>Wondering which factors affect microbial function? Excellent question, here are a few:</p><ul><li>What your microbes are consuming</li><li>What your microbes are producing</li><li>Metabolic pathways that are active in your microbes</li><li>How your microbes interact with each other</li><li>How your microbes change behavior in different environments</li></ul><p>Our understanding of these complex interactions are what allows us to provide you with bio-individual food recommendations.</p><h3>Harnessing the Power Artificial Intelligence</h3><p>Wouldn’t it be so wonderful if everything in the body happened in a linear fashion? If that were the case we could say things like, “When you have X microbe, you’ll get Y result.” We totally understand the desire to know what specific microbes do in the body. But your body is beautifully complex and things are not that simple.</p><p>The number of microbial interactions in the body is vast. These intricate interactions depend on many other factors present (or not present). With billions of data points to analyze, categorize, and understand — we’ve harnessed the power of Artificial Intelligence.</p><p>We get it — the grandiose term “Artificial Intelligence” can feel a bit abstract. But AI is already at work in your life on a daily basis. We’ve come to accept AI in other areas of our lives:</p><ul><li>You know how Spotify and Pandora build recommended playlists for you based on that one song you love so much? <em>AI makes that happen.</em></li><li>Or how Siri has gotten significantly better in the past 2 years? <em>That’s AI at work.</em></li><li>How about when your bank notifies you something strange has happened with your account? <em>AI again.</em></li><li>And how does Uber smoothly transition between pick up points and finding riders along the driver’s route? <em>You guessed it, AI.</em></li></ul><p>Unlike these AI examples, when you use Viome you have a window into the inner workings of AI analysis in the palm of your hands. <em>That can be both exciting and confusing.</em></p><p><strong>Every update is AI at work to improve your personalized recommendations.</strong> AI is a powerful tool that allows us to examine and reveal patterns and relationships within your gut microbiome, so you receive actionable recommendations.</p><h3>Arming Our Users With Powerful Information</h3><p>Viome uses metatranscriptomic technology, which was developed in Los Alamos National Laboratories. With this technology, we have already uncovered so many insights that put into question so called health “truths.” Here are just a few:</p><ol><li><strong>Some “healthy” foods aren’t always healthy </strong>— About 30% of our customers lack the right microbes to digest oxalates, which are found in foods like spinach, beets, rhubarb, and bran. Oxalates can be harmful for some people and with Viome, you’ll know where you stand.</li><li><strong>Too much protein can be harmful </strong>— We are taught that you need to eat your protein to stay healthy and strong. But if you’re consuming too much, you could be contributing to increased inflammation and decreased longevity. Fortunately, your Viome recommendations will tell you how much protein you really need.</li><li><strong>Not all antioxidant or anti-inflammatory foods work for everyone </strong>— Polyphenols in foods were usually considered very healthy, but unless you have the appropriate microbes that use specific polyphenols, you will not benefit from them. This means you could be wasting your time, money, and taste buds eating something you think is healthy when it is not benefiting you.</li></ol><p><strong>Ultimately, our recommendations optimize your metabolism. </strong>We used comparative testing to cross examine our Gut Intelligence results with metabolic intelligence results and in a recent study with continuous blood glucose monitors, which we then incorporated with our AI. Our AI now uses this information to tell you about your metabolic responses to foods, which is one of the ways we calculate your bio-individualized food recommendations.</p><p>We approach everything with a discerning eye, which has lead to discovery after discovery — <em>and YOU are part of this.</em></p><p><strong>This is one of the most important reasons we developed the Viome app. So as we learn, you can learn too. </strong>Every time your app updates, you are getting the highest quality gut microbiome science delivered to you.</p><h3>Welcome to the Gut Microbiome Revolution!</h3><p>When you use Viome’s technology, you have a direct data stream that comes straight from our laboratories, and our knowledge base. With that power, you can expect constant improvement.</p><p>We understand the confusion the new update may have caused and we hope you now have better insight into how this whole process works. It is our mission to bring you the most cutting edge science about your individual gut microbiome, so you can makes necessary changes to improve your life.</p><p><strong>By being part of the Viome team, you are part of the gut microbiome revolution.</strong> You can leverage our revolutionary technology by simply following the recommendations you’ve received on your Viome app (minus any known sensitivities or allergies). We receive testimonials on a daily basis reinforcing the effectiveness of our recommendations based on our technology — it is truly inspiring! Armed with new and powerful insight into your gut microbiome, we hope you can achieve your next level of improved wellbeing.</p><p><strong>MyViome Spotlight on Lisa Bilyeu</strong></p><p><a href="http://bit.ly/LisaTestimony">http://bit.ly/LisaTestimony</a></p><p>Resources:</p><ul><li><a href="https://www.ncbi.nlm.nih.gov/pubmed/15489351">https://www.ncbi.nlm.nih.gov/pubmed/15489351</a></li><li><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520958/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520958/</a></li></ul><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=93227dc07f62" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Metatranscriptomic Analysis — The Next Frontier in Microbiome Technology is Available Today]]></title>
            <link>https://medium.com/@MyViome/metatranscriptomic-analysis-the-next-frontier-in-microbiome-technology-is-available-today-a2dd5018deb9?source=rss-bcea8272ef68------2</link>
            <guid isPermaLink="false">https://medium.com/p/a2dd5018deb9</guid>
            <category><![CDATA[health]]></category>
            <category><![CDATA[wellness]]></category>
            <category><![CDATA[sequencing]]></category>
            <category><![CDATA[microbiome]]></category>
            <dc:creator><![CDATA[Viome]]></dc:creator>
            <pubDate>Fri, 06 Apr 2018 22:28:35 GMT</pubDate>
            <atom:updated>2018-04-06T22:28:35.200Z</atom:updated>
            <content:encoded><![CDATA[<p><em>Naveen Jain</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*i8bw2HCpz5vZLEhonNB-8w.png" /><figcaption><em>Image: Pixabay</em></figcaption></figure><blockquote><strong>Summary</strong><br>DNA-based gut microbiome analyses have been available for years. They include 16S and metagenomic sequencing technologies, which have identified strong connections between the gut microbiome and human health. However, these technologies cannot provide accurate food and supplement recommendations that can improve many aspects of human health. To do this comprehensively, it is critical to measure what the microbes are doing for you, the host — which can only be done with the technology called “metatranscriptomics,” which measures microbial activity (which microbes are present and how active they are), and also their biochemical functions (what they are doing).</blockquote><p>Recently, gut microbiome testing has received well-deserved criticism due to the widespread use of the 16S gut microbiome analysis method. <a href="#_edn1">[i]</a>,<a href="#_edn2">[ii]</a> The 16S technology identifies bacteria by sequencing a portion of their 16S ribosomal RNA genes.<a href="#_edn3">[iii]</a> As a result, this technology cannot detect other living microorganisms in the gut, such as viruses, phages, yeast, fungi and mold. Moreover, this technology cannot even identify all bacteria. 16S sequencing is also limited by the level of detail it can produce; bacteria can mostly be identified at the taxonomic levels of genus or higher. Despite these serious limitations, 16S sequencing continues to be used by many companies because it is inexpensive.</p><p>In some recent scientific publications, the 16S technology has been shown to produce lots of false results. A peer-reviewed study by Edgar determined that 16S sequencing of known bacterial communities resulted in a 56% to 88% false positive rate of predicted genus names.<a href="#_edn4">[iv]</a> In other words, more than 50% of the genera reported in the results are not actually present in the sample. Ultimately, the study concludes that “biological inferences obtained using these methods are…not reliable”. Since many bacterial genera (plural of genus) comprise various types of bacteria, predicting responses to potential interventions is difficult when the microbiome is examined at the genus level. This problem is amplified when the technology produces false positives at such alarming rates.</p><p>Here at Viome, we are so convinced that 16S sequencing is worthless that we actually remove 16S ribosomal RNAs from our samples. We call this step Removal of Non-informative RNAs (RNR), because 16S RNAs are not informative.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/724/1*WQJdo9uiKUPO3H54Ym3_Yw.png" /><figcaption>After sending the same stool sample to American Gut and uBiome, a journalist found that her results from the two companies were very different, with Firmicutes-to-Bacteroidetes ratio being the opposite. Retrieved from Retrieved from: <a href="https://www.sciencenews.org/blog/gory-details/here%E2%80%99s-poop-getting-your-gut-microbiome-analyzed">https://www.sciencenews.org/blog/gory-details/here%E2%80%99s-poop-getting-your-gut-microbiome-analyzed</a></figcaption></figure><p>Fortunately, sequencing technologies have progressed beyond the commonly used 16S method. Some companies have implemented metagenomic analysis of gut samples. This is a relatively simple technology, but significantly more expensive than 16S. While metagenomic analysis can identify most microbes (except for RNA viruses and phages) at much higher resolution than 16S, it provides no insight into the functions of these organisms. Both 16S and metagenomic methods have another drawback: they analyze DNA, not live microorganisms. DNA is very stable, so even DNA from the food we consume and from dead microorganisms finds its way into stool samples, thus wasting sequencing data and confounding the analyses.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Ccbyx_TcsLW8PyhuxkPklA.png" /></figure><p>The introduction of metatranscriptomic analysis has transcended the limitations of all other gut microbiome methods and demonstrated the gut microbiome’s promising potential as a target for personalized nutrition. Metatranscriptomic analysis allows for the detection of <em>all living </em>organisms (bacteria, archaea, viruses, phages, yeast, fungi, mold, parasites, etc.) at the highest resolution (strain level), precise quantification of the activity of these organisms, and most importantly, analysis of their functions that directly impact our own metabolism and health. Major differences between other gut microbiome analysis methods and Viome’s state-of-the-art metatranscriptomic technology are outlined in the table below.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/946/1*Dhz94qAbbUfohb84-Hgjtg.png" /></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/1012/1*H0SIqCxqRnUmve0l4_lXqg.png" /></figure><p>Metatranscriptomic analysis allows microbiome researchers to measure gene expression of all living organisms, identifying how gut microorganisms interact with their human environment and elucidating functional changes that contribute to health and disease.[i] Metatranscriptomic technology has allowed Viome to generate personalized, actionable nutritional recommendations. Automated analyses of individual and collective data allow for unprecedented insights into the metabolic activities and functional capacity of an individual’s microbiome. These insights are used to provide a personalized action plan for optimizing wellness through specific diet, supplement and lifestyle modifications.</p><p>Research has established that the gut microbiome influences and interacts with a wide range of human physiological functions, especially those related to metabolism and the digestive, immune, and neuroendocrine systems.<a href="#_edn2">[ii]</a>,<a href="#_edn3">[iii]</a>,<a href="#_edn4">[iv]</a>,<a href="#_edn5">[v]</a>,<a href="#_edn6">[vi]</a>,<a href="#_edn7">[vii]</a>,<a href="#_edn8">[viii]</a>,<a href="#_edn9">[ix]</a>,<a href="#_edn10">[x]</a> Specific microbiome functions have been identified that can influence specific human physiological functions. For example, research has shown that an important microbiome metabolic product called butyrate — produced from bacterial fermentation of dietary fiber — plays an important role in immune balance by stimulating the production of T regulatory cells, which help to suppress inflammation. Butyrate also helps to support the energy needs of colon cells, and contributes to metabolic and neurological health. Traditional ways of assessing butyrate production via 16S or metagenomic analyses are poor indicators, since these methods can only tell which organisms are present, but not what they are doing. Viome’s metatranscriptomic technology determines the activity of butyrate production and related pathways to obtain a much more accurate assessment. If Viome’s analysis demonstrates low levels of butyrate production in an individual, then — depending on the overall assessment of an individual’s microbiome and wellness — Viome can recommend higher intake of foods rich in certain dietary fibers that are known to stimulate butyrate production.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*ZH7_vF_l5HcYRVPzw-pzFg.png" /></figure><p>Why is it so important to tell if and how butyrate is actively made? Because the proprietary pathway analysis methods and functional scoring logic that Viome uses can suggest different recommendations based on the levels of specific butyrate production pathways and specific butyrate-producing organisms. This means you can get more personalized recommendations suggesting you focus on “feeding the good guys” (giving those butyrate producers more fibers they love), “adding the good guys” (taking probiotic-rich foods and supplements with butyrate producers themselves), “balancing out the bad guys” (other species which may suppress butyrate producers), or supplementing with butyrate, and/or different combinations of the above-listed actions for various lengths of times and with particular amounts/ doses that suit your gut microbiome and your functional profile best.</p><p>While butyrate is known to be produced by specific microbes, some pathway insights gained from metatranscriptomic data analyses also point to unexpected findings, not previously tied to any specific organisms. For instance, microbial organisms in your gut are often seen actively transporting and metabolizing a number of known environmental toxins, such as methylnaphthalene/naphthalene (could come from smoke, overly-fried foods or moth balls), toluene, acrylamide/ acrylate, atrazine, and many of the known persistent organic pollutants known to be present in the environment. They can come from plastics, rubber kitchen utensils, gels and emulsifiers, aerosols, shampoos, and many personal care products, as well as from unfiltered contaminated water sources. Seeing unusually high toxin-processing pathway activities can warrant some additional recommendations, which include more antioxidants, as well as liver support, in the food or supplement form.</p><p>There are thousands of other molecular pathway insights that allow Viome to understand which functions are actively carried out by the gut microbiome, allowing food and supplement recommendations specifically tailored to individual functional profiles. For example, if enzymes that are known to degrade proteins and membranes are overly active, they may lead to damage of mucosal lining and contribute to “leaky gut”. If such a trend is observed, Viome may suggest eating specific fiber-rich foods, bone broth (for collagen), adding specific probiotics, and taking supplements, like glutamine or zinc carnosine. Viome’s technology can also determine the energy sources of individual microbes based on active enzymes and functional pathways. Based on this functional profile, Viome offers recommendations for foods in relative amounts that would most benefit individual gut health.</p><p>In addition to energy production, we can determine which byproducts the microbes are synthesizing in the process — such as ammonia, cyanide, peroxide, some ketones, or other compounds. If microbes are creating these byproducts, they can be mitigated with specific nutrition and supplement plans. The synthesis of fats, as well as the types of fats (long- or short-chain, saturated or unsaturated) can be determined based on specific enzyme levels. If beneficial short-chain fatty acids (SCFAs) are being produced by microbiota, Viome’s technology can predict how this will affect human metabolism, mood, and even eating behavior — and make subsequent recommendations to correct the imbalances. If the biosynthesis pathway of a key SCFA is low, but breakdown enzymes are high, Viome can determine probiotic recommendations that would replenish the gut with beneficial butyrate producers.</p><p>Only at Viome is it possible to pinpoint the microbial pathway activities specific to production of particular bacterial products, such as indoles, lipopolysaccharides (LPS), reactive oxygen species (ROS)-like molecules, hydrogen sulfide or sulfites, putrescine, or cadaverine, and/or a number of neurotransmitters. The quantity of these molecules suggest if individuals will benefit more from foods like turmeric and pineapple or green tea, or supplements, such as curcumin, bromelain, resveratrol, or glutathione. Viome’s metatranscriptomic analysis can determine if glutathione is actively being produced by gut microbes, which is indicative of microbiota mitigating a hostile gut environment.</p><p>Viome’s technology extracts information from the human microbiome that has never been available before. As described in this article with a few examples, it generates many clear, scientifically-backed recommendations based on the high-resolution microbiome data. This technology allows Viome’s scientific and AI experts to develop the unique analytical methods that give you personalized guidance with foods and supplements that really address what is going on in your gut.</p><p>Do you know if you are getting what you need from your microbiome? Do you know if you are a “good host” to your microbes and the functions they perform for you? Viome can help you find out — and guide you on your path to ultimate wellness.</p><p><em>Naveen Jain is the CEO of Viome, Inc.</em></p><p><a href="#_ednref1">[i]</a> Ranjan et al., “Analysis of the Microbiome.”</p><p><a href="#_ednref2">[ii]</a> Qin et al., “A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing.”</p><p><a href="#_ednref3">[iii]</a> Sussman and Tang, <em>Molecular Medical Microbiology Three-Volume-Set.</em></p><p><a href="#_ednref4">[iv]</a> Edgar, “Accuracy of Microbial Community Diversity Estimated by Closed- and Open-Reference OTUs.”</p><p><a href="#_ednref1">[i]</a> Bashiardes, Zilberman-Schapira, and Elinav, “Use of Metatranscriptomics in Microbiome Research.”</p><p><a href="#_ednref2">[ii]</a> Chervonsky, “Microbiota and Autoimmunity.”</p><p><a href="#_ednref3">[iii]</a> Karlsson et al., “Symptomatic Atherosclerosis Is Associated with an Altered Gut Metagenome.”</p><p><a href="#_ednref4">[iv]</a> Rogers et al., “From Gut Dysbiosis to Altered Brain Function and Mental Illness.”</p><p><a href="#_ednref5">[v]</a> Zhang and Zhang, “Microbiota Associated with Type 2 Diabetes and Its Related Complications.”</p><p><a href="#_ednref6">[vi]</a> Harach et al., “Reduction of Abeta Amyloid Pathology in APPPS1 Transgenic Mice in the Absence of Gut Microbiota.”</p><p><a href="#_ednref7">[vii]</a> David et al., “Diet Rapidly and Reproducibly Alters the Human Gut Microbiome.”</p><p><a href="#_ednref8">[viii]</a> Scheperjans et al., “Gut Microbiota Are Related to Parkinson’s Disease and Clinical Phenotype.”</p><p><a href="#_ednref9">[ix]</a> Baxter et al., “Microbiota-Based Model Improves the Sensitivity of Fecal Immunochemical Test for Detecting Colonic Lesions.”</p><p><a href="#_ednref10">[x]</a> Parekh, Balart, and Johnson, “The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.”</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a2dd5018deb9" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>